KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $2.2 million.

  • Staar Surgical's Change in Accured Expenses fell 1840.0% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 13371.36%. This contributed to the annual value of $3.4 million for FY2024, which is 6736.24% down from last year.
  • Staar Surgical's Change in Accured Expenses amounted to $2.2 million in Q3 2025, which was down 1840.0% from -$12.7 million recorded in Q2 2025.
  • Staar Surgical's Change in Accured Expenses' 5-year high stood at $8.1 million during Q1 2021, with a 5-year trough of -$12.7 million in Q2 2025.
  • Moreover, its 5-year median value for Change in Accured Expenses was $3.3 million (2021), whereas its average is $1.2 million.
  • Data for Staar Surgical's Change in Accured Expenses shows a peak YoY increase of 20513.07% (in 2025) and a maximum YoY decrease of 85123.23% (in 2025) over the last 5 years.
  • Quarter analysis of 5 years shows Staar Surgical's Change in Accured Expenses stood at $3.4 million in 2021, then crashed by 50.99% to $1.7 million in 2022, then soared by 166.31% to $4.4 million in 2023, then soared by 58.83% to $7.0 million in 2024, then plummeted by 68.08% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, -$12.7 million for Q2 2025, and $5.3 million during Q1 2025.